318 related articles for article (PubMed ID: 34717620)
21. Functional protein aggregates: just the tip of the iceberg.
Villaverde A; Corchero JL; Seras-Franzoso J; Garcia-Fruitós E
Nanomedicine (Lond); 2015; 10(18):2881-91. PubMed ID: 26370294
[TBL] [Abstract][Full Text] [Related]
22. Selective expression of the soluble product fraction in Escherichia coli cultures employed in recombinant protein production processes.
Gnoth S; Simutis R; Lübbert A
Appl Microbiol Biotechnol; 2010 Aug; 87(6):2047-58. PubMed ID: 20535469
[TBL] [Abstract][Full Text] [Related]
23. Application of an E. coli signal sequence as a versatile inclusion body tag.
Jong WS; Vikström D; Houben D; van den Berg van Saparoea HB; de Gier JW; Luirink J
Microb Cell Fact; 2017 Mar; 16(1):50. PubMed ID: 28320377
[TBL] [Abstract][Full Text] [Related]
24. Soluble expression of pullulanase from Bacillus acidopullulyticus in Escherichia coli by tightly controlling basal expression.
Chen A; Li Y; Liu X; Long Q; Yang Y; Bai Z
J Ind Microbiol Biotechnol; 2014 Dec; 41(12):1803-10. PubMed ID: 25312401
[TBL] [Abstract][Full Text] [Related]
25. [Cloning and expression of the gene of chymotrypsin-like protease of human kallikrein-7 in Escherichia coli and isolation of recombinant protein].
Zakabunin AI; Mishukova OV; Khrapov EA; Sergeichev DS; Boiarskikh UA; Sverdlov ED; Filipenko ML
Mol Gen Mikrobiol Virusol; 2007; (2):21-5. PubMed ID: 17598454
[TBL] [Abstract][Full Text] [Related]
26. A new Gateway vector and expression protocol for fast and efficient recombinant protein expression in Mycobacterium smegmatis.
Goldstone RM; Moreland NJ; Bashiri G; Baker EN; Shaun Lott J
Protein Expr Purif; 2008 Jan; 57(1):81-7. PubMed ID: 17949993
[TBL] [Abstract][Full Text] [Related]
27. Purification and refolding of Escherichia coli-expressed recombinant human interleukin-2.
Esfandiar S; Hashemi-Najafabadi S; Shojaosadati SA; Sarrafzadeh SA; Pourpak Z
Biotechnol Appl Biochem; 2010 Apr; 55(4):209-14. PubMed ID: 20236092
[TBL] [Abstract][Full Text] [Related]
28. Efficient recovery of recombinant CRM197 expressed as inclusion bodies in E.coli.
Park AR; Jang SW; Kim JS; Park YG; Koo BS; Lee HC
PLoS One; 2018; 13(7):e0201060. PubMed ID: 30021008
[TBL] [Abstract][Full Text] [Related]
29. [In vitro renaturation of proteins from inclusion bodies].
Porowińska D; Marszałek E; Wardęcka P; Komoszyński M
Postepy Hig Med Dosw (Online); 2012 Jun; 66():322-9. PubMed ID: 22706118
[TBL] [Abstract][Full Text] [Related]
30. Accurate quantitation for in vitro refolding of single domain antibody fragments expressed as inclusion bodies by referring the concomitant expression of a soluble form in the periplasms of Escherichia coli.
Noguchi T; Nishida Y; Takizawa K; Cui Y; Tsutsumi K; Hamada T; Nishi Y
J Immunol Methods; 2017 Mar; 442():1-11. PubMed ID: 27939301
[TBL] [Abstract][Full Text] [Related]
31. Inclusion Body Production in Fed-Batch and Continuous Cultivation.
Kittler S
Methods Mol Biol; 2023; 2617():87-102. PubMed ID: 36656518
[TBL] [Abstract][Full Text] [Related]
32. Strategies for the production of recombinant protein in Escherichia coli.
Gopal GJ; Kumar A
Protein J; 2013 Aug; 32(6):419-25. PubMed ID: 23897421
[TBL] [Abstract][Full Text] [Related]
33. Overproduced Brucella abortus PdhS-mCherry forms soluble aggregates in Escherichia coli, partially associating with mobile foci of IbpA-YFP.
Van der Henst C; Charlier C; Deghelt M; Wouters J; Matroule JY; Letesson JJ; De Bolle X
BMC Microbiol; 2010 Sep; 10():248. PubMed ID: 20920169
[TBL] [Abstract][Full Text] [Related]
34. [Solubilization Specificities Interferon beta-1b from Inclusion Bodies].
Zhuravko AS; Kononova NV; Bobruskin AI
Bioorg Khim; 2015; 41(4):403-10. PubMed ID: 26615635
[TBL] [Abstract][Full Text] [Related]
35. Protein recovery from inclusion bodies of Escherichia coli using mild solubilization process.
Singh A; Upadhyay V; Upadhyay AK; Singh SM; Panda AK
Microb Cell Fact; 2015 Mar; 14():41. PubMed ID: 25889252
[TBL] [Abstract][Full Text] [Related]
36. Two distinct states of Escherichia coli cells that overexpress recombinant heterogeneous β-galactosidase.
Zhao Y; He W; Liu WF; Liu CC; Feng LK; Sun L; Yan YB; Hang HY
J Biol Chem; 2012 Mar; 287(12):9259-68. PubMed ID: 22303013
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of Escherichia coli cell disruption and inclusion body release using nucleic acid binding fluorochromes and flow cytometry.
Medwid RD; Krebs L; Welch S
Biotechniques; 2007 Dec; 43(6):777-82. PubMed ID: 18251254
[TBL] [Abstract][Full Text] [Related]
38. Inclusion Bodies: Status Quo and Perspectives.
Kopp J; Spadiut O
Methods Mol Biol; 2023; 2617():1-13. PubMed ID: 36656513
[TBL] [Abstract][Full Text] [Related]
39. Influence of pH control in the formation of inclusion bodies during production of recombinant sphingomyelinase-D in Escherichia coli.
Castellanos-Mendoza A; Castro-Acosta RM; Olvera A; Zavala G; Mendoza-Vera M; García-Hernández E; Alagón A; Trujillo-Roldán MA; Valdez-Cruz NA
Microb Cell Fact; 2014 Sep; 13():137. PubMed ID: 25213001
[TBL] [Abstract][Full Text] [Related]
40. A simple and effective strategy for solving the problem of inclusion bodies in recombinant protein technology: His-tag deletions enhance soluble expression.
Zhu S; Gong C; Ren L; Li X; Song D; Zheng G
Appl Microbiol Biotechnol; 2013 Jan; 97(2):837-45. PubMed ID: 23250226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
